Replies to post #509273 on NorthWest Biotherapeutics Inc (NWBO)

[Fireman02360]

If they really want a piece we wouldn't be selling for 70¢/sh. NWBO is not a well-kept secret.

I dont really pay attention to the "70¢/sh". For me its more about the market-cap, not SP. With a MC of $730 million its in-line with another promising pre-commercial bio I own...Anavex Life Sciences, who is about to be approved to treat Retts and Phase 3 Alz data by years end and has a MC of $750 million. Keep in mind Anavex has roughly $150 million in cash, no debt and shares-outstanding of roughly 80 million. MC of $750 million. They are on the cusp of cracking Alzheimer's, reported excellent P2 Parkinson's results and about to be approved for Retts within the 6-8 months. If the market was broadcasting failure of either of these two bios, I can assure you the MC for both would be <$250 million, particularly in this market. Keep in mind Anavex Trades on the NASDAQ. NW Bio is holding up very well recently all the while trading on the OTC. Dont be fooled. NW Bio is in a very good position.

-Fireman

[Fireman02360]

Getting approval in the UK does not guarantee we will be profitable. Just saying.

100% wrong. I dont subscribe to the $15-20-25 SP (yet), but upon approve in the UK NW Bio will be at $4-5 a share. And will be profitable within 6-8 months after approval.

-Fireman